Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$657M |
| 2 |
Apple
AAPL
|
+$610M |
| 3 |
Amazon
AMZN
|
+$587M |
| 4 |
AstraZeneca
AZN
|
+$319M |
| 5 |
Snowflake
SNOW
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$323M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$273M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$121M |
| 4 |
PFPT
Proofpoint, Inc.
PFPT
|
+$98.6M |
| 5 |
JD.com
JD
|
+$89.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.03% |
| 2 | Financials | 13.72% |
| 3 | Healthcare | 12.6% |
| 4 | Consumer Discretionary | 10.97% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NIU
2801
Niu Technologies
NIU
$193M
| $123K | ﹤0.01% |
5,311
| – | – |
|
2802
Aligos Therapeutics
ALGS
$34.9M
| $121K | ﹤0.01% |
313
+207
| +195% | +$81.9K |
|
2803
Stem
STEM
$52.7M
| $121K | ﹤0.01% |
253
-78
| -24% | -$41K |
|
|
CMBM
2804
DELISTED
Cambium Networks
CMBM
| $120K | ﹤0.01% |
3,312
+1,987
| +150% | +$78.6K |
|
2805
Vertex
VERX
$1.94B
| $120K | ﹤0.01% |
6,257
+4,241
| +210% | +$82K |
|
|
MRUS
2806
DELISTED
Merus
MRUS
| $119K | ﹤0.01% |
5,427
+4,227
| +352% | +$90.7K |
|
2807
Vital Farms
VITL
$525M
| $119K | ﹤0.01% |
6,797
+3,129
| +85% | +$56.2K |
|
2808
KRONOS Worldwide
KRO
$989M
| $118K | ﹤0.01% |
9,502
+4,657
| +96% | +$61.6K |
|
|
BDSI
2809
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $117K | ﹤0.01% |
32,316
+18,384
| +132% | +$69.3K |
|
2810
Mission Produce
AVO
$1.17B
| $115K | ﹤0.01% |
6,281
+2,789
| +80% | +$54.9K |
|
|
CVE.WS
2811
DELISTED
Cenovus Energy Inc Warrants
CVE.WS
| $115K | ﹤0.01% |
19,766
-4,786
| -19% | -$23.2K |
|
2812
Occidental Petroleum Corp Warrants
OXY.WS
$32B
| $115K | ﹤0.01% |
9,775
| – | – |
|
2813
Relmada Therapeutics
RLMD
$527M
| $115K | ﹤0.01% |
4,391
+2,231
| +103% | +$59.7K |
|
2814
Blue Bird Corp
BLBD
$2.18B
| $114K | ﹤0.01% |
5,470
+3,215
| +143% | +$71.3K |
|
|
ATNX
2815
DELISTED
Athenex, Inc. Common Stock
ATNX
| $114K | ﹤0.01% |
1,891
+600
| +46% | +$43.7K |
|
2816
Annexon
ANNX
$886M
| $113K | ﹤0.01% |
6,079
+3,017
| +99% | +$61.2K |
|
|
LX
2817
LexinFintech Holdings
LX
$241M
| $113K | ﹤0.01% |
19,212
| – | – |
|
2818
SoundThinking
SSTI
$103M
| $113K | ﹤0.01% |
3,096
+1,692
| +121% | +$71K |
|
|
TCS
2819
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $113K | ﹤0.01% |
789
+432
| +121% | +$72.4K |
|
2820
Alto Ingredients
ALTO
$340M
| $111K | ﹤0.01% |
22,582
+13,579
| +151% | +$68.4K |
|
|
HGEN
2821
DELISTED
HUMANIGEN, INC.
HGEN
| $111K | ﹤0.01% |
18,724
+6,357
| +51% | +$89.3K |
|
2822
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.7B
| $110K | ﹤0.01% |
1,480
+480
| +48% | +$36.5K |
|
2823
MediaAlpha
MAX
$821M
| $109K | ﹤0.01% |
5,833
+3,025
| +108% | +$81.9K |
|
2824
Rimini Street
RMNI
$471M
| $109K | ﹤0.01% |
11,342
+6,716
| +145% | +$58.2K |
|
2825
VirnetX Holding Corp
VHC
$63.1M
| $109K | ﹤0.01% |
1,399
+632
| +82% | +$51.7K |
|
Similar funds
Legal & General Group's Q3 2021 Portfolio in Review
As of Q3 2021, Legal & General Group held 3,551 positions worth $308B, up 2.9% from $299B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Legal & General Group deployed $10.7B of net new capital in Q3 2021, opening 77 new positions and adding to 2,293 existing holdings. Its largest new stake was AstraZeneca: 2,738,007 shares worth $329M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was JD.com, an estimated $89.3M trimmed.
- Legal & General Group's largest Q3 2021 buy was AstraZeneca: 2,738,007 shares worth $329M.
- Legal & General Group added most to Microsoft in Q3 2021, an estimated $657M increase.
- Legal & General Group's biggest Q3 2021 reduction was JD.com, cutting an estimated $89.3M.
- Legal & General Group fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $323M.
- Legal & General Group's ten largest holdings make up 22% of its $308B portfolio in Q3 2021.
- Legal & General Group opened 77 new positions and closed 55 in Q3 2021.
- Legal & General Group's portfolio value rose 2.9% quarter-over-quarter to $308B.
Based on Legal & General Group's 13F filing for Q3 2021, filed 15 Nov 2021.